Lenampicillin hydrochloride
Cat. No.：YN250026
| 产品名称: | Lenampicillin hydrochloride |
| CAS No.: | 80734-02-7 |
| Chemical Name: | (2S,5R,6R)-6-[[(2R)-Aminophenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester Hydrochloride; KB 1585; KBT 1585; Takacillin; Varacillin; [2S-[2α,5α,6β(S*)]]-6-[(Aminophenyla |
| Synonyms: | 盐酸仑氨苄西林; KBT 1585 hydrochloride |
| 分子量: | 497.95 |
| 分子式: | C₂₁H₂₄ClN₃O₇S |
| SMILES: | O=C([C@@H]1N(C2=O)[C@]([C@@H]2NC([C@@H](C3=CC=CC=C3)N)=O)([H])SC1(C)C)OCC(OC4=O)=C(O4)C.Cl |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Lenampicillin hydrochloride (KBT 1585 hydrochloride) 是氨苄西林的口服前药，是一种有效的-内酰胺类抗菌(beta-lactam antibacterial) 剂，可抑制细菌的青霉素结合蛋白(转肽酶)。与氨苄西林相比，Lenampicillin 有改善吸收、减少副作用的作用，并应用于化脓性皮肤软组织感染的研究。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Saito, A. et al.: Chemother., 42, 209 (1983)
Tsukamoto, G. et al.: Curr. Chemother. Immunother. Proc. Int. Congr. Chemother., 1, 142 (1982)
Yamabe, S. et al.: Chemioterapia, 3, 60 (1984)
